Business Wire

IDEMIA

26.6.2020 10:32:12 CEST | Business Wire | Press release

Share
IDEMIA and Treezor Launch the First Eco-friendly Payment Card by Onlyone, a French Fintech Firm

IDEMIA teamed up with Treezor over three years ago to develop a broad range of groundbreaking products like metal cards and new look / new-feel cards – colored layers, bushed metal finish, transparent - targeting key French neobanks and fintechs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200626005102/en/

This collaboration between IDEMIA, the global leader in Augmented Identity and Treezor the French banking-as-a-service market leader, has today culminated in the launch of the first ever eco-friendly card by a fintech in France. This move ties in with both companies’ green initiatives while meeting consumer demand for sustainable solutions.

Backed by longstanding design, development and production know-how, IDEMIA was able to offer Treezor a low-natural-resource-consuming card without compromising at all on security or end-user convenience. As part of its environmental strategy, IDEMIA reaffirms its commitment to move away from today’s linear take-make-waste model and fundamentally rethink the way we design, use and reuse plastics.

Onlyone, first eco-friendly neobank1

Onlyone2 , a startup that markets itself as the first ever genuinely environmentally friendly fintech, will be the first recipient of this new 85+% recycled PVC card that is due to be launched with its existing customers in September 2020.

“We strive to adopt green practices throughout our operations by going paperless and developing digital and eco-friendly bank card solutions. Bank cards are manufactured from industrial waste-based recycled PVC in line with circular economy principles, which seek to cut waste of natural resources and minimize industrial waste. IDEMIA also obtained “Environmental Claim Validation Summary” certification from its recycled PVC supplier “UL Environment Inc.” said Amanda Gourbault, Executive Vice-President for Financial institutions activities at IDEMIA.

"We are grateful Treezor and IDEMIA give us this amazing opportunity to be the first Fintech in France to offer an eco-responsible card. With this new card, we are laying the first brick in supporting our customers towards a low-carbon lifestyle" said Kamel Nait Outaleb, Co-founder and CEO of Onlyone .

“We are proud that Onlyone will issue this very first card that embraces our and Onlyone’s values and meets today’s consumer expectations. We are thrilled to have a chance to contribute to #Tech4Good who share what we are trying to achieve. A big thank you to IDEMIA for bringing its technological expertise” said Eric Lassus, Treezor cofounder and CEO.

About IDEMIA

IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.

Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.

With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit www.idemia.com / Follow @IdemiaGroup on Twitter

About Onlyone:

Created at the end of 2018, Onlyone is an independent, 100% digital, ethical and positive impact Fintech. Founded by Kamel Naït-Outaleb, Amine Melouk and Matthias Rouberol, three experienced entrepreneurs in banking and digital, its mission is to create a different, more virtuous payment account model, in order to reposition the banking world at the heart of society and the realities of our time.

To meet social and environmental challenges, Onlyone is reinventing account management services, adapting them to help create a transparent and sustainable banking world. In addition to monitoring day-to-day account operations, Fintech enables its users to understand, monitor and reduce the environmental impact of their consumption thanks to an exclusive environmental impact score and change management tools. It also enables them to contribute to financing projects with a high social and environmental impact, such as carbon offsetting projects or the fight against malnutrition, in a simple way and at no extra cost. To find out more go to Onlyonecard.eu.

About Treezor

Éric Lassus and Xavier Labouret founded Treezor in 2016 and in 2019 sold it to French bank Société Générale. Today Treezor is a French white-label payment services fintech. The firm can market its services in Europe based on its electronic money operating license and its Mastercard principal member status. The firm manages the entire payment process via its platform encompassing purchase, card issue, Xpay, wire transfers, P2P, KYC and more. The firm dedicates a large proportion of its funds to developing new technologies and has 80-plus staff in Paris and Rennes. To learn more about Treezor, go to www.treezor.com , follow us on Twitter @TreezorBanking and on our LinkedIn page.

----------------------------

1 As defined by the French Prudential Supervision and Resolution Authority in its 2019 report titled “Neobanks seeking profits”, ‘neobank’ means Banking-as-a-Service platforms like Treezor.
2 Treezor payment services agent

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye